Press Releases

05.06.13
A&G Pharmaceutical Receives $300,000 Research Grant from Avon at the 11th Annual Avon Walk for Breast Cancer Washington DC

03.06.12
Mayo Medical Laboratories signs agreement with A&G Pharmaceutical, Inc.

09.28.10
A&G Pharmaceutical Awarded Phase II SBIR Grant for Development of GP88 Drug Candidate Targeted to Breast Cancer

05.02.10
Eighth Annual Avon Walk for Breast Cancer Washington, D.C. Raises More Than $6.5 Million

06.19.09
A&G Pharmaceutical Receives 2009 Maryland Business Incubator Award

12.14.07
A&G Pharmaceutical Receives $870,000 Grant from Avon Foundation to Advance Innovative Blood Diagnostic Test for Early Detection of Breast Cancer

08.31.07
A&G Pharmaceutical Receives Equity Investment from Olympus Corporation

12.15.06
A&G Pharmaceutical to Present at San Antonio Breast Cancer Symposium

06.07.06
A&G Pharmaceutical and Celltrion Announce Bioprocess Development and Manufacturing Agreement for A&G Anti-GP88 Cancer Therapeutic Antibody

02.21.06
Greater Baltimore Committee Awards A&G Pharmaceutical Entrepreneurial Spirit Award

10.12.05
A&G Pharmaceutical Selected to Present at Mid-Atlantic Bio Conference

09.08.05
A&G Pharmaceutical Completes Series A Financing

▶  Press Releases

▶  News Articles

▶  Published Research